Specific Effects of Anti-Hypertensive Treatment in an Older Patient with Dementia

All published articles of this journal are available on ScienceDirect.

CASE REPORT

Specific Effects of Anti-Hypertensive Treatment in an Older Patient with Dementia

Jadwiga Attier Zmudka1 , * Open Modal Jean Marie Sérot1 Salif Dao2 Claire Sorel3 Anne-Sophie Macaret4 Olivier Balédent5
Authors Info & Affiliations
The Open Neurology Journal • 17 Apr 2017 • CASE REPORT • DOI: 10.2174/1874205X01711010015

Abstract

Dementia is one of the most common health problems in the world. Alzheimer’s disease (AD) is the most common form of dementia. The presence of vascular risk factors such as hypertension (HT) may increase the risk of AD [1,2]. The relation between blood pressure (BP) and dementia has been the subject of numerous epidemiological studies, midlife HT is a risk factor for dementia and AD [3-7] but the association between HT and risk of dementia is lower in the older population [8].

A fair modulation of an antihypertensive treatment, based on the cognitive status of the elderly, can avoid multiple complications.

A case of an older for whom cognitive improvement and reduced risk of falls were noticed after mild blood pressure elevation is reported.

Keywords: Hypertension, Dementia, Cerebral blood flow, Stroke, Asprin, MRI.

CASE REPORT

An 88-year-old woman living alone at home was consulted for cognitive decline. She presented hypertension for more than 40 years, diagnosed after her menopause. She had also coronary disease, osteoporosis, osteoarthritis and dyslipidemia. Her treatment was olmesartan 20 mg every two days (which is not standard according to guidelines), since 7 years (her previous treatment with angiotensin-converting enzyme inhibitors was replaced due to cough), bisoprolol 10 mg, nicorandil 10mg, aspirin 75 mg, ezetimibe 10 mg, cholecalciferol and alendronic acid 70 mg/2800 UI, fentanyl 12 µg every 3 days. Drugs were administrated by a visiting nurse. There was no modification in her treatment for more than one year. The medical questioning showed that the patient did not know the reason for our consultation, her birth date nor the number of her children. Her daughter revealed that the patient was an insomniac. Her neighbors found her few times lost outside her home.

The clinical examination showed an extrapyramidal rigidity without tremor.

She had no visual troubles, but had hearing loss. The geriatric scales showed a Charlson score [9] at 4, activities of daily living (ADL) [10] at 4/6, instrumental activities of daily living (IADL) [11] at 1/8, timed up and go test was not performed as the walk and equilibrium were altered. The primary cognitive assessment revealed a severe cognitive decline with Mini-Mental State Examination (MMSE) [12] at 11/30, the confusion assessment method (CAM) [13] was at 0/4 and mini geriatric depression scale (miniGDS) [14] at 2/4. The clinical dementia rating (CDR) [15] was at 3.

During hospitalization in acute geriatrics unit, we noted repeated falls with traumatic consequences. Falls occurred mostly in the morning, related to low blood pressure (by 110/60).

The orthostatic hypotension test was negative many times, excluding an autonomic failure.

Neuropsychological assessment (MMSE, clock test, trail making test, Mattis dementia rating scale, Rey-Osterrieth complex figure) confirmed dementia, according to DSM IV criteria [16]. There was no hallucination or variability of cognitive tests. Cognitive profile and neuroimaging abnormalities suggested a mixed dementia [17], vascular part involving executive alterations and impaired processing speed and hippocampal part related to the episodic memory deficit.

Fig. (1). A: The T2* Magnetic Resonance Imaging shows three areas of semi recent ischemia in the white matter, including: frontal right posterior, right posterior transitional zone and beside the left central sulcus.
B: A sagittal T2 sequence was used as localizers to select the anatomical levels for the Phase Contrast Magnetic Resonance Imaging used for the flow quantification over the cardiac cycle (CC). Acquisition plane was selected to be perpendicular to the vertebral and internal carotid arteries.
C: The graph shows the curves of the mean cerebral arterial blood flows, for the patient and a healthy elderly subject. This quantitative acquisition shows a decrease of pulsatility of the arterial cerebral blood flow of the patient over the cardiac cycle.

24 h rhythmic monitoring showed normal sinus rhythm with minor disorders like ventricular extrasystole, not sufficient to justify the falls.

24 h blood pressure monitoring showed a mean arterial pressure by 120/53 mmHg, based only on the day period; monitoring was not available by night due to behavioral disturbances. The minimal values achieved as 102/43 mm Hg.

Magnetic resonance imaging (MRI) showed three areas of semi recent ischemia (roughly 3 weeks ago). Vascular alterations were presented by periventricular and deep white matter leukoencephalopathy (Fazekas II), and it was hippocampal atrophy (Scheltens IV). A phase contrast MRI flow sequence (PCMRI), measuring the cerebral arterial circulation [18], performed in a research purpose, showed a decrease in arterial pulsatility (Fig. 1). This finding could be related to a hypotension as demonstrated by the blood pressure monitoring.

We think that the dementia syndrome occurred earlier as her daughter reported minor mnesic problems for few years. We hypothesized that the multiple strokes were caused by low cerebral blood flow in patient treated with antihypertensive drugs in her midlife, her antihypertensive treatment being the same for many years. The diastolic hypotension supported this hypothesis. However, this patient had long-term high blood pressure, dyslipidemia and a history of coronary heart disease and the hypothesis of thromboembolic mechanisms could not be formally eliminated.

In an aim to preserve the quality of life of our patient, antihypertensive treatment with the sartans was stopped and β-blockers decreased to 2.5 mg. The mean arterial blood pressure increased up to 150/90 mm Hg. Moreover, the MMSE improved to 16/30 and the patient did not fall anymore during more than one year after.

DISCUSSION

Hanon's study indicated a significant decrease in BP in patients with AD after one year of follow up, independently of age, gender, body mass index and antihypertensive therapy. The largest decrease in BP was observed in patients with the severest impairment in dementia at the baseline, suggesting that blood pressure decrease seems to be mainly a secondary phenomenon in Alzheimer's disorders [19]. The decrease in BP could increase amyloid genesis and taupathy strategic locations of the brain that regulate BP. Recent study [20] showed also reduced brain circulation leading to continuous hypoperfusion that increases generation β-amyloid peptides particularly APO-ε4 carriers and thus mildly elevated blood pressure seems to benefit mental and physical functions in these older patients. The APO E haplotype of our patient was unavailable; this is a limitation of our study.

The mean arterial blood pressure by 150/90 obtained after drugs modification was closer to guideline recommendations in elderly [21, 22]. However, the elderly in upper age are rarely included in major hypertension studies.

The PC-MRI flow sequence is rapid (around 2 minutes), doesn’t require an injection and brings quantitative information of the cerebral arterial flow over the cardiac cycle. Nevertheless, this blood flow investigation is still not used commonly in neurodegenerative pathology.

In conclusion, we report the case of a patient with a severe cognitive decline, secondary to multiple strokes caused by low cerebral blood flow in patient treated with antihypertensive drugs since her midlife, which have not been modified when the first signs of memory loss appeared. The decrease of antihypertensive drugs improved her cognitive functions and protected her from falling consequences.

Physicians who deal with patients suffering from neurodegenerative diseases must keep in mind that the antihypertensive medication should be reevaluated.

AUTHOR CONTRIBUTIONS

All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Attier-Zmudka: Medical care, case reporter, drafting of manuscript, critical revision of manuscript. .

Sérot: Supervision, critical revision of manuscript.

Dao: Interpretation of magnetic resonance imaging.

Sorel: Interpretation of rhythmic monitoring

Macaret: Neuropsychological statement interpretation.

Balédent: Administrative, technical, material support, supervision and interpretation of imaging flow data.

SPONSOR’S ROLE

None.

CONFLICT OF INTEREST

The author confirms that this article content has no conflict of interest.

ACKNOWLEDGEMENTS

Declared none.

Elements of Financial/Personal Conflicts JAZ JMS SD CS ASM OB
Yes No Yes No Yes No Yes No Yes No Yes No
Employment or Affiliation
x x x x x x
Grants/Funds
x x x x x x
Honoraria
x x x x x x
Speaker Forum
x x x x x x
Consultant
x x x x x x
Stocks
x x x x x x
Royalties
x x x x x x
Expert Testimony
x x x x x x
Board Member
x x x x x x
Patents
x x x x x x
Personal Relationship
x x x x x x

REFERENCES

1
Joas E, Bäckman K, Gustafson D, et al. Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension 2012; 59(4): 796-801.
2
Rönnemaa E, Zethelius B, Lannfelt L, Kilander L. Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 2011; 31(6): 460-6.
3
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 2006; 5(9): 735-41.
4
Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000; 21(1): 49-55.
5
Reijmer YD, van den Berg E, van Sonsbeek S, et al. Dementia risk score predicts cognitive impairment after a period of 15 years in a nondemented population. Dement Geriatr Cogn Disord 2011; 31(2): 152-7.
6
Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347(9009): 1141-5.
7
Watfa G, Marteau JB, Rossignol P, et al. Association study of gene polymorphisms involved in vascular alterations in elderly hypertensives with subjective memory complaints. Dement Geriatr Cogn Disord 2010; 30(5): 440-8.
8
Kennelly S, Collins O. Walking the cognitive minefield between high and low blood pressure. J Alzheimers Dis 2012; 32(3): 609-21.
9
Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011; 173(6): 676-82.
10
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-9.
11
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9(3): 179-86.
12
Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-98.
13
Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990; 113(12): 941-8.
14
Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 1999; 14(10): 858-65.
15
Ousset PJ, Andrieu S, Reynish E, Puel M, Vellas B. Clinical evaluation of dementia in a cohort of 358 patients with the French version of the Clinical Dementia Rating (CDR) scale. Rev Med Interne 2003; 24(Suppl. 3): 283s-7s.
16
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology 1984; 34(7): 939-44.
17
Zekry D, Hauw JJ, Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 2002; 50(8): 1431-8.
18
Balédent O, Fin L, Khuoy L, et al. Brain hydrodynamics study by phase-contrast magnetic resonance imaging and transcranial color doppler. J Magn Reson Imaging 2006; 24(5): 995-1004.
19
Hanon O, Latour F, Seux ML, Lenoir H, Forette F, Rigaud AS. Evolution of blood pressure in patients with Alzheimers disease: a one year survey of a French Cohort (REAL.FR). J Nutr Health Aging 2005; 9(2): 106-11.
20
de Oliveira FF, Chen ES, Smith MC, Bertolucci PH. Associations of Blood Pressure with Functional and Cognitive Changes in Patients with Alzheimers Disease. Dement Geriatr Cogn Disord 2016; 41(5-6): 314-23.
21
Allen M, Kelly K, Fleming I. Hypertension in elderly patients: recommended systolic targets are not evidence based. Can Fam Physician 2013; 59(1): 19-21, 22-4.
22
OBrien E, Parati G, Stergiou G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31(9): 1731-68.